Drug
Who makes eribulin mesylate?
16 companies list eribulin mesylate as a human prescription drug, including under the names Halaven. Forms: injection; solution. Routes: intravenous.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing eribulin mesylate
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Apotex Inc.Canada | injection | ANDAANDA218047 | 2 | 6 |
| Baxter Healthcare CorporationUnited States | injection | ANDAANDA217250 | 1 | 16 |
| Sun Pharmaceutical Industries LimitedIndia | injection | ANDAANDA218743 | 1 | 13 |
| Glenmark Pharmaceuticals Inc., USAIndia | injection | ANDAANDA218142 | 1 | 9 |
| Eisai Inc.United States | injection | NDANDA201532 | 1 | 6 |
| Sandoz Industrial Products S.AAustria | injection | ANDAANDA214310 | 1 | 5 |
| GLAND PHARMA LIMITEDIndia | injection | ANDAANDA218047 | 1 | 4 |
| Hikma Pharmaceuticals USA Inc.United States | injection | ANDAANDA218281 | 1 | 4 |
| BSP Pharmaceuticals SpAItaly | injection | NDANDA201532 | 1 | 1 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd.China | injection | ANDAANDA218743 | 1 | 1 |
| BluePoint Laboratories Inc. | solution | ANDAANDA214850 | 1 | 0 |
| Dr. Reddys Laboratories Limited | injection | ANDAANDA217473 | 1 | 0 |
| Kindos Pharmaceuticals Co., Ltd. | injection | ANDAANDA218142 | 1 | 0 |
| Long Grove Pharmaceuticals, LLC | solution | ANDAANDA214850 | 1 | 0 |
| Northstar Rx, LLC, | solution | ANDAANDA214850 | 1 | 0 |
| XGen Pharmaceuticals DJB, Inc. | injection | ANDAANDA219054 | 1 | 0 |
Bulk ingredient listings
- Eisai Inc.United States · 2 NDC
- Chongqing Biocare Pharmaceutical Ltd.China · 1 NDC
- Chongqing Sintaho Pharmaceutical Co., Ltd.China · 1 NDC
- Dr. Reddys Laboratories Limited · 1 NDC
- Emcure Pharmaceuticals LimitedIndia · 1 NDC
- Formosa Laboratories, Inc.Taiwan · 1 NDC
- Lianyungang Runzhong Pharmaceutical Co., Ltd.,China · 1 NDC
- Wisdom Pharmaceutical Co., Ltd.China · 1 NDC
Orange Book patents
2 unexpired patents list eribulin mesylate as the active ingredient, expiring between Jan 2027 and Jul 2027. Application holder: EISAI INC.
Enquiry
Common questions
- Who makes eribulin mesylate?
- 16 companies list eribulin mesylate as a human prescription drug in the openFDA NDC Directory, led by Apotex Inc., Baxter Healthcare Corporation, Sun Pharmaceutical Industries Limited, Glenmark Pharmaceuticals Inc., USA, Eisai Inc.. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Is there a generic Halaven?
- 14 companies list eribulin mesylate under an abbreviated new drug application (ANDA), the application type used for generics, and 2 under an NDA or BLA. Listing status is from the NDC Directory; it is not a statement of availability.
- Who supplies eribulin mesylate active ingredient?
- 8 companies list eribulin mesylate as a bulk ingredient, including Eisai Inc., Chongqing Biocare Pharmaceutical Ltd., Chongqing Sintaho Pharmaceutical Co., Ltd., Dr. Reddys Laboratories Limited.